Erik Viktor Siewertz
Director of Finance/CFO at IRLAB THERAPEUTICS AB
Net worth: 298 983 $ as of 2024-06-29
Network origin in Erik Viktor Siewertz first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 24 | |
Investigium AB
1
| Private Company | 1 | |
Vestigium AB
1
| Private Company | 1 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Erik Viktor Siewertz via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| RECKITT BENCKISER GROUP PLC | Household/Personal Care | Sales & Marketing | |
| University of Bath | College/University | Masters Business Admin | |
| BIOINVENT INTERNATIONAL AB | Biotechnology | Director/Board Member Director/Board Member | |
| MEDIVIR AB | Pharmaceuticals: Major | Chairman Chief Executive Officer Director of Finance/CFO Director/Board Member | |
Svenskt Näringsliv
 Svenskt Näringsliv Miscellaneous Commercial ServicesCommercial Services Svenskt Näringsliv provides consulting services. It focuses on protection, support, and promotion of the interests of businesses. The firm provides its members with knowledge in a number of areas including labor market and law, taxes, corporate law and intellectual property, economics and macro analysis, constitutional and legal protection, security and risk management, and trade policy. The company was founded on March 29, 2001 and is headquartered in Stockholm, Sweden. | Miscellaneous Commercial Services | Director/Board Member Chief Executive Officer | |
AstraZeneca AB
 AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden. | Miscellaneous Commercial Services | Chief Executive Officer Corporate Officer/Principal Corporate Officer/Principal | |
Royal Pharmaceutical Society of Great Britain
 Royal Pharmaceutical Society of Great Britain Miscellaneous Commercial ServicesCommercial Services The Royal Pharmaceutical Society of Great Britain provides expertise and support to its member pharmacists. The private company is based in Great Britain. Alex MacKinnon has been the CEO of the British company since 2010. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| Karolinska Institutet | College/University | Corporate Officer/Principal Doctorate Degree Corporate Officer/Principal Doctorate Degree | |
DCC Healthcare Ltd.
 DCC Healthcare Ltd. Medical DistributorsDistribution Services DCC Healthcare Ltd. supplies medical, surgical, and laboratory equipment and pharmaceuticals to the Irish healthcare sector. The company is headquartered in Stillorgan, Ireland. | Medical Distributors | Chief Executive Officer | |
| ALLIGATOR BIOSCIENCE AB | Biotechnology | Investor Relations Contact Director/Board Member Director/Board Member | |
| Chalmers University of Technology | College/University | Corporate Officer/Principal Chairman Undergraduate Degree | |
| University of Uppsala | College/University | Masters Business Admin Doctorate Degree Graduate Degree Corporate Officer/Principal | |
Agendia NV
 Agendia NV Medical/Nursing ServicesHealth Services Agendia NV discovers and develops products for clinical management of cancer. It operates as a commercial-stage molecular diagnostic company that focuses on the discovery, development, and commercialization of products to improve the quality of life for cancer patients. The company was founded by Rene Bernards and Laura van't Veer in 2003 and is headquartered in Amsterdam, the Netherlands. | Medical/Nursing Services | Director/Board Member | |
| University of Stockholm | College/University | Director/Board Member Graduate Degree | |
| PLUS THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member | |
| University of Lund | College/University | Director/Board Member | |
| Erasmus University Rotterdam | College/University | Doctorate Degree | |
Alecta AB
 Alecta AB Investment ManagersFinance Alecta AB provides asset management services. The company is headquartered in Stockholm, Sweden. | Investment Managers | Corporate Officer/Principal Director/Board Member | |
| International Institute for Management Development | College/University | Undergraduate Degree | |
| VIVESTO AB | Pharmaceuticals: Generic | Director/Board Member Chief Executive Officer | |
| BioCrine AB | Director/Board Member Director/Board Member | ||
Royal Swedish Academy of Engineering Sciences
 Royal Swedish Academy of Engineering Sciences Miscellaneous Commercial ServicesCommercial Services The Royal Swedish Academy of Engineering Sciences (IVA) is an organization that brings together around 1,300 academy members and 250 companies to bridge the gap between academia, business, and politics. The non-profit company is based in Stockholm, Sweden. The Swedish company's aim is to work towards people's ability to contribute positively to society. The organization runs an internship program called Tekniksprånget, which gives young people in Sweden the opportunity to test the engineering profession through a four-month paid internship. The program has been running since 2012 and aims to inspire more people to choose a higher technical education. The CEO of the company is Björn O. Nilsson. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
| University of Gothenburg | College/University | Doctorate Degree Graduate Degree Undergraduate Degree Graduate Degree Undergraduate Degree Corporate Officer/Principal Undergraduate Degree | |
Aenova Holding GmbH
 Aenova Holding GmbH Medical DistributorsDistribution Services Aenova Holding GmbH provides supplies to the pharmaceutical and healthcare industries. The firm develops, produces, and markets solid dosage products such as soft and hard capsules, tablets, film-coated tablets, and effervescent tablets. Its services include production, supply chain management, packaging, support and analytics. The company was founded in 2008 and is headquartered in Starnberg, Germany. | Medical Distributors | Chief Executive Officer | |
Agendia, Inc.
 Agendia, Inc. Pharmaceuticals: MajorHealth Technology Agendia, Inc. operates as a molecular diagnostics company. It develops and markets FFPE-based genomic diagnostic products, which help support physicians with their treatment decisions. Agendia?s tests can help physicians assess a patient?s individual risk for metastasis, it benefits from chemo, hormonal or combination therapy. The company was founded by Laura van't Veer and Ren? Bernards in 2003 and is headquartered in Irvine, CA. | Pharmaceuticals: Major | Director/Board Member | |
| Astra Hässle AB | Chief Executive Officer Chief Executive Officer | ||
SwedenBIO Service AB
 SwedenBIO Service AB Miscellaneous Commercial ServicesCommercial Services SwedenBIO Service AB is a non-profit company that develops biotechnology, diagnostics, pharmaceuticals, and medical technology. It also offers counseling, education, opinion formation, and investigations. The company was founded in 2002 and is headquartered in Stockholm, Sweden. | Miscellaneous Commercial Services | Chairman Director/Board Member | |
Hjärt-Lungfonden Svenska Nationalföreningen mot hjärt
 Hjärt-Lungfonden Svenska Nationalföreningen mot hjärt Miscellaneous Commercial ServicesCommercial Services Hjärt-Lungfonden Svenska Nationalföreningen mot hjärt is a non-profit organization based in Stockholm, Sweden. and has subsidiaries in Sweden. The organization's main objective is to raise funds for selected Swedish heart and lung research to help people live longer and healthier lives. The Swedish company works together with individuals and companies to collect and distribute funds for heart and lung research. The organization's vision is to create a world free from heart and lung disease. Kärlkramp, which is a temporary reduction of blood flow in the heart's coronary vessels and the main symptom is a squeezing chest pain, is one of the diseases they focus on. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member Director/Board Member | |
| SWEDISH ORPHAN BIOVITRUM AB | Pharmaceuticals: Major | Chief Executive Officer Corporate Officer/Principal | |
| Culture Group Ltd. | Director/Board Member | ||
| Kulturtuben AB | Director/Board Member | ||
Lumos Pharma Sub, Inc.
 Lumos Pharma Sub, Inc. Medical/Nursing ServicesHealth Services Lumos Pharma Sub, Inc. develops and commercializes a novel treatment for the rare disease creatine transporter deficiency. It focuses on bringing novel therapies to patients afflicted with unmet medical needs in severe, rare, and genetic diseases. The firm's technology LUM-001 is a repurposed small molecule that is a kinetically similar analog of creatine and has shown promising therapeutic potential for the treatment of creatine transporter deficiency. Lumos Pharma was founded by Richard J. Hawkins in 2010 and is headquartered in Austin, TX. | Medical/Nursing Services | Director/Board Member | |
| TOLERANZIA AB | Biotechnology | Director/Board Member | |
Betagenon Sweden AB
 Betagenon Sweden AB Pharmaceuticals: MajorHealth Technology Betagenon AB engages in development of AMP-activated protein kinase (AMPK) activator compounds chronic energy balance disorders diseases. The company was founded by Helena Edlund, Thomas Edlund and Olof Karlsson and is headquartered in Umea, Sweden. | Pharmaceuticals: Major | Chairman | |
| CERENO SCIENTIFIC AB | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Oblique Therapeutics AB
 Oblique Therapeutics AB Pharmaceuticals: MajorHealth Technology Oblique Therapeutics AB is a privately held Swedish biotech company that develops innovative new medicines for severe diseases with a large unmet medical need, focusing on pain and advanced cancer. The company is based in Gothenburg, Sweden. The company uses abiprot®, an in-house-invented, next-generation antibody platform that can generate antibodies with programmed function against the full human proteome. The portfolio comprises several antibody candidates and the small molecule ot-1096 in triple-negative breast cancer. In addition, two antibody programs are run in R&D collaborations with pharma companies. The company was founded in 2015 by Jan Owe Owesson Orwar, and Christer Nordstedt has been the CEO of the company since 2022. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer Chairman | |
| Carlsson Research AB | Founder Founder Founder Director of Finance/CFO Chief Tech/Sci/R&D Officer Founder | ||
| SAVARA INC. | Pharmaceuticals: Major | Director/Board Member | |
Gesynta Pharma AB
 Gesynta Pharma AB Pharmaceuticals: MajorHealth Technology Gesynta Pharma AB develops and manufactures novel oral treatments for patients with chronic inflammatory conditions. The company was founded by Gunilla Anders Ekström, Charlotte Elisabet Edenius, Urban Paulsson, Ralf Morgenstern, Per-Johan Göte Jakobsson and Patric Stenberg in 2017 and is headquartered in Solna, Sweden. | Pharmaceuticals: Major | Director/Board Member | |
| ALZECURE PHARMA AB | Biotechnology | Chief Tech/Sci/R&D Officer | |
| van Es Consulting AB | Director/Board Member | ||
| Lorensbergsteatern | Director/Board Member | ||
| LUMOS PHARMA, INC. | Pharmaceuticals: Major | Director/Board Member | |
| Olsson Solutions AB | Director/Board Member | ||
RGNT Electric AB
 RGNT Electric AB Motor VehiclesConsumer Durables RGNT Electric AB is a Swedish company that specializes in electric motorcycles. The company is based in Kungsbacka, Sweden. The company's range of motorbikes is both timeless and forward-thinking. RGNT Electric was founded in 2019 by Jonathan Åström. Göran Karlsson has been the CEO of the company since January 12, 2023. | Motor Vehicles | Director/Board Member | |
| Betagenon Bio AB | Chairman | ||
CINDA PHARMA AB
 CINDA PHARMA AB Miscellaneous Commercial ServicesCommercial Services CINDA PHARMA AB is a Swedish company that engages in the research and development of pharmaceutical products. The private company is located in Sweden. | Miscellaneous Commercial Services | Director/Board Member Chairman | |
Amplifier TX AB
 Amplifier TX AB BiotechnologyHealth Technology Part of Cambrian BioPharma, Inc., Amplifier TX AB is a Swedish biopharmaceutical company that develops clinical molecule AMPK activators. The private company is based in Umeå, Sweden. The company was founded in 2023 by Thomas Edlund, Helena Edlund. James Hall has been the CEO of the company since 2023. | Biotechnology | Director/Board Member |
Statistics
International
| Sweden | 36 |
| United States | 6 |
| United Kingdom | 5 |
| Netherlands | 3 |
| Ireland | 2 |
Sectoral
| Health Technology | 17 |
| Consumer Services | 10 |
| Commercial Services | 8 |
| Distribution Services | 3 |
| Health Services | 3 |
Operational
| Director/Board Member | 158 |
| Corporate Officer/Principal | 50 |
| Chairman | 50 |
| Chief Executive Officer | 36 |
| Independent Dir/Board Member | 34 |
Most connected contacts
- Stock Market
- Insiders
- Erik Viktor Siewertz
- Company connections
